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Executive Summary 
Purpose of guidance 
The intent of this guidance is to assist leadership in the City of San Antonio and Bexar County as 
they formulate plans to re-open our community. This guidance is based on existing public health 
evidence, data, and expertise, and informed by shared values, including a commitment to equity and 
service to the community. 
Guiding principles 
Our recommendations are based on the following guiding principles: beneficence, we prioritize the 
community’s well-being and recognize that health and economic prosperity are tightly linked; 
evidence-based decision making and responsiveness to new information; respect for individual 
freedom and privacy; trustworthiness, including teamwork, transparency, and accountability; and 
equity, a commitment to protect those who are medically at risk or marginalized. 
Process 
Our team is made of health experts, including infectious diseases and pulmonary critical care 
specialists, hospital leaders, epidemiologists, ethicists, and public health experts. To craft this 
guidance, we gathered and synthesized existing knowledge regarding COVID-19 in our community 
and in the medical literature. We examined other community re-opening plans. Consensus guidance 
was developed by the entire team, in collaboration with a larger group of advisors for technical 
expertise, and is reflected in this report. 
Indicators and capacity 
Reopening businesses and other sectors of the economy in San Antonio and Bexar County will 
require careful consideration of the risk of someone becoming infected with SARS-CoV-2, the virus 
that causes COVID-19, across many settings. It must be clearly stated that re-opening businesses 
and other sectors of the economy may increase the risk of COVID-19 in our community. Not all 
factors for transmission of this virus can be known with certainty. 
However, there are certain signs, or indicators, that tell us we are effectively addressing the COVID-
19 epidemic in our community. These progress indicators include: 
 
A sustained decline in the number of new cases of COVID-19 ≥ 14 days 
 
The ability to perform tests for the virus in all people with symptoms of COVID-19, 
their close contacts, and those in public facing roles 
 
Effective contact tracing capacity to identify all close contacts of people diagnosed with 
COVID-19 and offer testing to those for whom it is indicated 
 
A prepared healthcare system that can safely care for all patients, including sufficient 
hospital capacity, workforce, and PPE for healthcare workers 
For safe re-opening, we recognize that our community needs more education about COVID-19, 
improved access to testing for COVID-19, and an expansion of our existing public health capacity 
for contact tracing and follow up. We also must focus our efforts on those who are medically at risk 
and on marginalized populations. 
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Phases 
In alignment with federal guidance for reopening, we recommend a phased process. The first is our 
current state: Stay Home, Work Safe. Phase II includes staged reopening, determined by specific 
risks of activities, in the setting of expanded testing and contact tracing capacity and sufficient health 
system resources to care for all patients. Phase three represents a further easing of restrictions that 
would be possible in the setting of effective treatment or other medical or public health advances. 
Phase four begins once COVID-19 is no longer a threat to our community and focuses on 
improving our readiness for the next public health threat. In each phase, businesses and enterprises 
should employ universal hand-hygiene and surface-cleaning. At each phase, the indicators 
mentioned above should be closely monitored. Warning indicators, such as the rate of new 
laboratory-confirmed cases in the community or the stress on our health systems, must be examined 
for signs that increased public health safety measures may be needed, including the need to retreat to 
measures taken in prior phases. 
Strategies by sector 
Guidance is provided for businesses and other sectors of the economy based on the risk of someone 
becoming infected with SARS-CoV-2 in that setting. Risk is determined by: contact intensity, the 
number of people within 6 feet of one another and the duration of that contact; number of contacts: 
the number of people in the setting at one time; and modification potential, how easy it is to change 
the activity or the setting to reduce risk. This guidance can be used by the COVID-19 Economic 
Transition Team to craft recommendations for specific sectors of the economy. 
Marginalized populations 
The team recognizes that racial and economic disparities are vast and deep in San Antonio and 
Bexar County. This guidance requests that our community prioritize efforts for those most impacted 
by the COVID-19 pandemic by focusing response and recovery support in low-income 
communities, communities of color including immigrants, and LGBTQIA+ communities. This is an 
intersectional strategy that ensures that all who are highest risk are reached for assistance, including 
the medically at risk, people with disabilities, low wage frontline workers, incarcerated individuals, 
housing insecure individuals, and seniors. When these individuals are also low-income or from 
communities of color, they are the most at risk. 
Breakthroughs 
Any guidance must be adaptable to new developments. Over the next six months or more, new 
research and breakthroughs in testing and treatment will require changes to the current plans. Our 
recommendations provide information regarding how the development of new testing modalities or 
a safe and effective treatment or vaccine would impact our community response. 
A way forward 
Our team is cautiously optimistic that our community can navigate through stages of phased re-
opening. This approach requires commitment from all members of our community to protect 
ourselves and each other by following safety guidance. Only by working together and caring for one 
another will we emerge from the COVID-19 pandemic.  
COVID-19 Health Transition Team Report – April 27, 2020 Page 11 
Statement of Guiding Principles 
The COVID-19 Health Transition Team is committed to creating recommendations based on the 
following guiding principles.1-3 
Beneficence 
Human health and economic prosperity are tightly linked. We prioritize human life in the face of the 
COVID-19 pandemic. We understand that continued, severe economic hardship undermines the 
health of the community as much as disease. We share San Antonio and Bexar County’s values of 
working safely, caring for people across the generations, protecting those who are medically at risk, 
and ensuring that no one is left behind. These shared values will guide a transition towards 
economic recovery, balanced by preserving the safety and integrity of our community. 
Evidence-based decision making and responsiveness to new information 
The best recommendations are those that are informed by current evidence. Recommendations for 
community practices should be grounded in public health literature and research. They should be 
responsive to newly emerging scientific information and local health and economic indicators. 
Respect for autonomy 
In the course of preserving public health and safety, the individual right to personal freedom and 
privacy must be respected. Any potential restrictions on individuals’ movement or private 
information requires community engagement and must involve the least restrictive means to achieve 
a mutually desired goal. 
Trustworthiness 
The members of this committee are committed to developing consensus guidelines that are unbiased 
and which place the community’s best interest above our own individual interests. To be worthy of 
the trust they are given, public officials and advisory councils should demonstrate teamwork, 
transparency, and accountability. We will communicate the evidence for and reasons behind 
recommendations clearly. We will also be honest about what we don’t yet know. 
Equity 
Fairness and equity require studying and implementing community practices that protect 
populations who are medically at risk or marginalized by inequitable systems and structures, 
including those with chronic illness, compromised immune systems, and group living situations. The 
health and economic inequities that already existed in our community are only intensified and 
pronounced in emergencies such as the COVID-19 pandemic. These impacts are most deeply felt in 
low-income and communities of color. 
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Process 
Figure 1. Visual depiction of the process by which the COVID-19 Health Transition Team 
developed guidance.  
CONVENING 
Ensuring diversity of expertise and viewpoints 
Discussion and agreement upon guiding principles 
 
 GATHERING RESOURCES 
Review existing re-opening plans 
Study medical literature 
Gather data from San Antonio/Bexar County 
CONSENSUS BUILDING  
Decisions made by consensus among entire team 
FEEDBACK 
INCORPORATION OF 
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Indicators and capacity 
Indicators 
Reopening businesses, schools, community venues, and other sectors of the economy in San 
Antonio and Bexar County will require careful consideration of the risk of someone becoming 
infected with SARS-CoV-2, the virus that causes COVID-19, across many settings. It must be 
clearly stated that re-opening businesses and other sectors of the economy may increase the risk of 
COVID-19 in our community. Not all factors for transmission of SARS-CoV-2 are known with 
certainty. 
To monitor the effects of re-opening San Antonio and Bexar County, specific indicators must be 
collected and analyzed. These metrics provide early recognition of changes in community 
transmission of COVID-19 or variations in stress on the healthcare system. Indicators may change 
over time as the epidemic evolves and other data become available. 
Due to the dynamic nature of infectious diseases, calculation of progress and warning indicators will 
be operationalized by the Unified Command of the San Antonio and Bexar County Emergency 
Operations Center: San Antonio Metropolitan Health District (Metro Health), San Antonio Fire 
Department (SAFD), and Southwest Texas Regional Advisory Council (STRAC). We propose the 
following progress indicators, reflective of an effective community response to COVID-19: 
 
A sustained decline in the number of new cases of COVID-19 ≥ 14 days 
 
The ability to perform tests for the virus in all people with symptoms of COVID-
19, their close contacts, and those in public facing roles 
 
Effective contact tracing capacity to identify all close contacts of people 
diagnosed with COVID-19 and offer testing to those for whom it is indicated 
 
A prepared healthcare system that can safely care for all patients, including 
sufficient hospital capacity, workforce, and PPE for healthcare workers 
 
We also recognize the need for continued monitoring of the epidemic as our community gradually 
re-opens. We propose the following warning indicators as signs that increased public health safety 
measures may be needed: 
 
A decrease in the number of days it takes for the number of COVID-19 cases in 
our community to double (doubling time) 
 
An increase in the percentage of COVID-19 tests suggestive of active infection 
that are positive for COVID-19 
 
An increase in indicators of health system stress, such as reductions in personal 
protective equipment, hospital bed, or ventilator capacity, and increases in 
emergency medical system calls 
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Significant changes in one or more of the indicators may indicate a relevant increase in community 
transmission rates of COVID-19 or increased stress on the healthcare system. This situation should 
prompt further assessment and consideration for the re-implementation of specific interventions. 
Action: Development of a clear, public facing dashboard of progress and warning indicators 
To promote transparency in the re-opening process, the team recommends that these indicators 
should be accessible to the public and updated regularly in the form of a community-facing 
dashboard. 
Capacity expansion 
For safe re-opening, we recognize that our community needs more education about COVID-19, 
improved access to testing for COVID-19, and an expansion of our existing public health capacity 
for contact tracing and follow up. 
Assessment of current capacity and expansion of COVID-19 testing 
To determine current capacity and need of testing, the following activities are recommended:  
• Assess specimen collection and lab material capacity  
• Assess specimen collection capacity (maximum daily number of tests available) across the 
county 
• Assess demand for specimen collection across the county 
• Assess community member testing need, symptoms, and previous access to testing 
Action: Increase testing for active infection 
Based on current knowledge of the epidemic, our team believes that testing for active infection 
should be expanded to a capacity of over 3,000 daily, which is twice our current testing capacity as 
of April 20, 2020.4 This number is based on the population of Bexar County and derived from 
Governor Abbott’s estimate that appropriate testing capacity for the state is 30,000/day, and aligns 
with population based estimates from the Harvard Global Health Institute.5 It is our hope that other 
laboratory testing capacity from private laboratories is able to supplement testing capacity in the 
coming weeks. Testing strategies should focus on: 
Symptomatic Goal to test all symptomatic individuals, with prioritization of: 
• Those who are medically at risk 
o Persons 65 years and older 
o Persons with chronic medical conditions such as hypertension, diabetes, obesity and 
immunosuppression 
o Healthcare providers 
o First responders 
• Marginalized communities 
o Communities of color including immigrants and asylum seekers of color 
o Low-income communities including housing insecure and homeless individuals 
o People with disabilities 
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o LGBTQIA+ communities 
Asymptomatic 
• As the epidemic evolves, testing of asymptomatic individuals in specific settings may be 
indicated. These may include: persons living and working in nursing homes, skilled nursing 
facilities, assisted living facilities, shelters, unsheltered homeless, and other congregate 
settings. 
Action: Assess asymptomatic transmission 
Because testing has been limited, and because only individuals with symptoms have been tested, no 
one knows how many people in Bexar County / City of San Antonio actually have the virus. In 
partnership with the San Antonio Fire Department’s Mobile Integrative Health Unit, the University 
of Texas Health Science Center San Antonio (UT Health), and University Health System, City of 
San Antonio Metropolitan Health District (Metro Health) plans to assess asymptomatic transmission. 
Plans for this innovative public health/academic partnership are forthcoming. 
Assessment of current capacity and expansion of contact tracing 
Contacts to cases are identified through the epidemiological investigation to identify individuals that 
have had close, prolonged contact with a confirmed COVID-19 case. Those with COVID-19 are 
placed in isolation and are given guidance on when they can be released from isolation. Close 
contacts (individuals that have prolonged exposure and within 6 feet proximity) are identified and 
information is obtained on these individuals. Each contact outside of the household is called by a 
team of nurses to inform them of their exposure and to place them on 14-day quarantine. 
Action: Increase contact tracing capacity at Metro Health 
We recommend that contact tracing efforts be increased to approximately 175 investigators, to align 
with national standards.4, 5 These investigators’ efforts should prioritize case tracing of people with 
COVID-19 in marginalized communities. Furthermore, the data management system and team will 
need to be augmented to deal with a surge of cases. The team may need to triple or quadruple in size 
depending on the number of cases being reported daily. 
Methodologies currently being pursued to increase contact tracing capacity: 
1) Metro Health/STRAC case reporting 
The City of San Antonio Metropolitan Health District (Metro Health) and the Southwest Texas 
Regional Advisory Council (STRAC) have developed a comprehensive system to identify and 
manage cases for persons with active COVID-19 disease. The system will capture positive cases 
through hospitals, clinics, and laboratories connected within the STRAC network and will allow 
Metro Health’s Epidemiology unit the ability to upload cases reported directly to the health 
department.  Metro Health will upload these cases daily at 9 pm, allowing our public health 
department to have full visibility to both negative and positive cases identified within the health 
district’s jurisdiction. This protocol will enable our Metro Health staff greater ability to perform 
investigations on COVID-19 index cases and conduct outreach to persons who have had contact 
with these individuals and may be at risk of exposure to the virus. 
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2) emocha Patient Mobile App for contact tracing  
Metro Health and Information Technology Services Department (ITSD) are engaging in a 
technology and staffing services development with emocha (a mobile health company) to provide a 
patient-facing application (Patient Mobile App) that allows all COVID-19–positive patients and 
exposed close contact individuals (who have the technical capability to do so) to daily self-monitor 
and report symptoms using emocha’s mobile and web applications. The Patient Mobile App allows 
patients to record and submit videos and report symptoms. Patients can also track their progress and 
send messages to Metro Health, or to emocha consultants who will provide data monitoring services. 
Installation of web-based software (Dashboard) allows Metro Health officials to live-monitor all 
COVID-19 positive patients and exposed individuals using the emocha patient-facing applications. 
The Provider-Facing Dashboard is a web-based software platform that allows Metro Health to 
enable patient access to the Patient Mobile App, review and track videos and health data submitted 
by patients, and access reports. Metro Health can use the Dashboard to send messages to patients 
that can be accessed through the Patient Mobile App. Metro Health can access analytics and reports 
through the Dashboard. 
Emocha will also provide additional staffing to augment the Metro Health and epidemiology teams 
to conduct Contact Tracing Interviews with close-contact individuals by using a dedicated team of 
emocha Enrollment Specialists. Once contacted, they can enroll them in the Patient Mobile App 
tools. 
By deploying this self-service technology to patients and individuals who have the ability to use it 
and by providing additional emocha staff to conduct contact tracing interviews, we will be able to 
redirect Metro Health and epidemiology staff resources to more complex cases and investigations 
and to those patients and individuals who do not have access to this form of technology, increasing 
the overall capacity of the team for contact tracing and monitoring. 
Support coordinated testing and contact tracing efforts through public-private partnerships 
Metro Health leads the COVID-19 Testing Task Force, a central body in which all stakeholders and 
agencies involved in COVID-19 testing are communicating regularly and thus can quickly adjust and 
make changes to the response as needed. To date, the Testing Task Force has developed and 
launched the COVID-19 self-screening tool, established definitions and guidance for COVID-19 
specimen collection and laboratory testing, developed cumulative data reports from public and 
private laboratories, and fostered partnership to expand free testing. 
As the epidemic evolves, the need for coordination between testing and contact tracing will only 
increase. Fostering public-private partnerships to support these efforts must continue to be a 
priority. 
Action: Leverage current Testing Task Force to create a combined Testing and Tracing Task Force 
We recommend that the current Testing Task Force membership be expanded to include 
coordination with contact tracing efforts. This body, led by Metro Health, will be able to rapidly 
review and assess alternate testing methods for COVID-19, including new modalities for antibody 
testing, rapid testing, and self-testing. Coordination with contact tracing efforts will allow 
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innovations to be rapidly deployed into the community, prioritizing the medically at-risk and 
marginalized populations described above. 
Action: Assure sufficient resources for effective, long term testing and tracing strategies 
For long term testing and contact tracing strategies to be successful, sufficient and timely resource 
allocation is required. We recommend allocation of resources towards this goal. This includes 
funding to hire staff and scale up outreach activities. Support from leaders and stakeholders to allow 
the rapid recruitment and training of volunteers and the infrastructure to support such strategies are 
also needed. 
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Phases to reopening San Antonio and Bexar County 
In alignment with federal guidance for reopening6, we recommend a phased process. The first is our 
current state: Stay Home, Work Safe. Phase II includes staged reopening, determined by specific 
risks of activities, in the setting of expanded testing and contact tracing capacity and sufficient health 
system resources to care for all patients. Phase III represents a further easing of restrictions that 
would be possible in the setting of effective treatment or other medical or public health advances. 
Phase IV begins once COVID-19 is no longer a threat to our community and focuses on improving 
our readiness for the next public health threat. In each phase, businesses and enterprises should 
employ universal hand-hygiene and surface-cleaning7.  
Throughout all phases, the indicators mentioned above should be closely monitored. Warning 
indicators, such as the rate of new laboratory-confirmed cases in the community or the stress on 
our health systems, must be examined for signs that increased public health safety measures may be 
needed, including the need to retreat to measures taken in prior phases. 
Figure 2. Phases overview 
 
Phase I: Stay Home, Work Safe 
During Phase I we have evidence of community spread of COVID-19 infections8. This means that 
confirmed cases cannot be traced back to a prior known case. To slow the spread, enforced 
mitigation measures include physical distancing, increased diagnostic testing, and optimizing 
healthcare system capacity (see Table 1). During this phase, we recommend that public health and 
local leadership coordinate with regional and state operations to mobilize resources, activate 
response teams and communicate directly with medically at-risk populations and settings. City and 
county authorities should provide enforcement for community mitigation strategies.  
The goals of Phase I are to: 
• Slow the transmission of COVID-19 
• Increase testing capacity  
• Ensure that the healthcare system has capacity to safely treat both COVID-19 patients and 
others requiring care 
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Table 1. Recommended Components of Phase I 
Maintain Physical Distancing 
Close community gathering 
spaces such as: schools, 
shopping centers, museums, 
gyms, places of worship… 
Promote telework 
Limit unnecessary domestic or international 
travel. Returning travelers from areas with 
community spread self-quarantine for 14 days 
and consider testing if indicated  
Stay-at-home advisories for 
transmission hot spots 
Cancel or postpone meetings and 
mass gatherings; promote virtual 
meetings and conferences 
Close dining areas but encourage restaurants 
and bars to provide takeout/delivery services 
 
Increase Testing Capacity 
Easily accessible testing with rapid turnaround time for: 
Hospitalized patients Healthcare workers and workers in 
public-facing roles 




Persons who live in congregate settings, such as homeless shelters, 
where physical distancing is challenging 
Outpatients with symptoms 
Assess and lower barriers to acceptability of testing 
Communicate all test results efficiently and confidentially to health authorities and to those tested 
Optimize Healthcare System Functioning 
Hospital surge plans to be optimized with regards to: 
Critical-care and expansion 
capacity 
Increase supply of personal protective 
equipment for healthcare workers 
Ventilators Staffing 
Implement Comprehensive Disease Monitoring Systems 
Detect increase in new cases Widespread testing Track and Contain new infections 
Monitoring should be initiated and maintained at places of work, including public buildings, healthcare facilities and 
restaurants, and should include twice daily temperature checks and symptom screening 
Intensive Contact Tracing 
New COVID-19 positive + 
patients should be isolated at 
home or in the hospital 
Close contacts of confirmed cases 
should be quarantined and 
monitored for 14 days 
Increase capacity for isolation and quarantine 
of individuals who cannot be isolated at home. 
Masking, Hand Hygiene, and Surface Cleaning 
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Thresholds for considering transition to Phase II 
Transition from Phase I to Phase II should be considered when the following progress indicators, 
to be operationalized by the Unified Command and the Emergency Operations Center, are met8: 
 
A sustained decline in the number of new cases of COVID-19 ≥ 14 days 
 
The ability to perform tests for the virus in all people with symptoms of COVID-19, 
their close contacts, and those in public facing roles 
 
Effective contact tracing capacity to identify all close contacts of people diagnosed 
with COVID-19 and offer testing to those for whom it is indicated 
 
A prepared healthcare system that can safely care for all patients, including sufficient 
hospital capacity, workforce, and PPE for healthcare workers 
 
Phase II: Staged reopening by risk assessment 
Phase II is a cautious step towards re-opening, determined by specific risks of activities, in the 
setting of expanded testing and contact tracing capacity and sufficient health system resources to 
care for all patients8. During this phase, we recommend various sectors start to re-open using a 
graduated approach. Suggested approaches and strategies to guide Phase II activities include: 
• Resuming activities takes place in stages 
o Intermediate stages are necessary to prevent a surge of infections after reopening, to 
permit strengthening of mitigation procedures, and allow additional time for 
observation of new case rates. 
o Services may be opened at reduced capacity initially, with a plan for increasing 
capacity if safety measures are met. 
o Risk tables in the “Risk Assessment by Sector” document may be used to determine 
sectors included in the first wave of reopening. 
• Continued risk mitigation 
o People who are working successfully from home may continue to do so. 
o Elderly and those with medical risk factors should still stay home as much as possible. 
o Continued limitations to sizes of gatherings and a prohibition on large gatherings 
(>50) 
o Employers should screen employees (temperature checks, symptom questions) 
o Employers should continue with masking, hand hygiene and surface cleaning  
• Team effort and community outreach 
o Develop strong partnerships, as well as clear and frequent communication between 
the public and health advisors 
o Safety monitoring methods should support the development of teamwork and 
mutual support. 
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o Continued education of the public regarding how to avoid infection (physical 
distancing, hand hygiene, environmental surface cleaning, and masking). 
• Recommended monitoring 
o All businesses and organizations agree to participate in health and hygiene 
monitoring for safety, permitting coaching visits from city/county health workers. 
o Monitoring may utilize existing health and safety workers and implemented with a 
sampling strategy for evaluating businesses and organizations. 
o System to ensure that individuals and businesses adhere to current safety guidelines 
o Testing of targeted asymptomatic high-risk populations such as Persons living in 
nursing homes, skilled nursing facilities, assisted living facilities, shelters, unsheltered 
homeless, and other congregate settings. 
Guidance for employees and employers 
We recommend that employers and employees consult the U.S. Center for Disease Control and 
Prevention (CDC) guidance regarding isolation of workers with COVID-19 and conditions 
permitting return to work.9 Employers could consider routine screening of employees with daily 
temperature checks and screening questions on arrival to work. Those with symptoms or fever 
should return home and be tested for COVID-19. Those with a negative test may return to work 
after 24 hours without fever. Those who are diagnosed with COVID-19 should follow the CDC 
recommendations for isolation mentioned above. For workplaces with clusters of new cases 
identified by Metro Health, asymptomatic testing should be considered.  
The Health Transition Team recommends that the Economic Transition Team develop strategies to 
promote sector-based affinity group support for risk mitigation within businesses in collaboration 
with local authorities. An example of a monitoring strategy is described in detail in Figure 3. 
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Figure 3. Example of a sector-specific monitoring strategy for risk mitigation. Please see section 
on risk assessment by sector for a description of risk. 





• Physical distancing, hand hygiene, environmental cleaning, and optimized air exchange1 must be 
implemented and sustained 
• Health and safety monitoring (sampling strategy to be designed by sector) will continue for a period of time 
• Monitoring outcomes are meant to be opportunities for process improvement and education 
• Sector-based affinity groups could assist each other within sectors; if one or more members of the sector 
performs poorly, the entire sector can assist with improvements in order to continue to expand to maximal 
business capacity 




Resume business at low/reduced operational capacity for an 
initial re-entry stage (2 to 4 weeks) 
 
Businesses provide workers with masks (disposable procedure 
masks or regularly laundered cloth masks), and workers and 
customers remain masked except when eating or drinking. 
 Low to Medium Risk  
 
Remain closed until Phase 3 
 
Exceptions could include theaters, museums, and other indoor 
leisure spaces to open reduced operational capacity if masking, 
hygiene, physical distancing, and air exchange standards sustained. 
 High Risk 
 
 After 2 to 4 weeks 
 
Enterprise or sector is 
adherent to health guidelines 
based on monitoring, increase 
operational capacity to an 
intermediate stage 
 
After an additional 2-4 weeks at 
intermediate operational 
capacity, if standards met, 
businesses may increase to full 
operational capacity. 
 
Entities not meeting hygiene 
standards or associated with 
new case clusters will be 
coached and remain at 
low/reduced capacity (or 
closed) until standards met 
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Table 2. Recommended components of Phase II 
Schools and Childcare facilities1 
Re-open in Phase II 
- Childcare facilities (daycare, preschools), with CDC/WHO 
mitigation resources, if not already open. 
- Noncontact school sports 
- Summer day camps without congregate living 
 
For Daycares and Summer camps consider COVID-19 lab 
testing/monitoring of counselors and screening of campers before 
camp 
Remain closed until authorities mandate re-opening or Phase III 
conditions are met: 
- Schools 
- Contact school sports 
- Summer overnight camps 
- Institutions of Higher Education 
 
Retail and Restaurants 
Re-open in Phase II: Gradual re-opening with low operational capacity and progress towards full operational capacity. 
 Physical distancing and other mitigation strategies will be critical. 
Outdoor Spaces 
Re-open in Phase II  
- Parks, walking paths/trails, dog parks 
- Athletic fields without crowds (≤ 50, outdoors, with 
distancing) 
- Outdoor Pools 
- Playgrounds, skateparks, other outdoor recreation spaces 
Remain closed until Phase III 
- Outdoor areas drawing crowds, determined by community 
feedback. 
Community Gathering Spaces 
Re-open in Phase II  
- Libraries (with physical distancing and risk mitigation) 
Remain closed until Phase III 
- Places of worship (except small gatherings allowing for 
physical distancing) 
- Community centers (except where physical distancing and 
hygiene can be enforced) 
 
Alternative strategy 
- Places of worship to open, with masks, alternate distance 
seating, staggered sessions to avoid large crowds. Virtual 
sessions for elderly and at-risk. Consider some sessions 
outside with distancing. 
Transportation 
Recommend avoiding nonessential travel, but do not ban travel.  
Consider COVID-19 testing and self-quarantine upon return, especially if travel to communities with higher COVID19 incidence than 
Bexar County 
Mass Gathering 
Recommend large concerts, gala fundraisers, Fiesta closed in Phase II 
Interpersonal Gatherings 
Allowed: Small social gatherings  
Example: birthday parties, preferred outdoors, ≤50 people 
Not allowed: Large social gatherings  
Example: Weddings, funerals, with >50 people outdoor preferred 
Masking, Hand Hygiene, and Surface Cleaning 
Continued from Phase I including: people who are ≥2 years should wear nonmedical fabric masks while in public 
1Childcare facilities are assessed a lower risk than schools because of a lower number of contacts and better modification 
potential, especially with CDC/WHO mitigation strategies. The team recognizes that without childcare options, it will be 
very difficult for San Antonio and Bexar County to successfully reopen. (See Table 4) 
Throughout Phase II, public health authorities will monitor the warning indicators, to be 
operationalized by the Unified Command and the Emergency Operations Center, as signs that 
increased public health safety measures may be needed. These may include: 
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A decrease in the number of days it takes for the number of COVID-19 cases in 
our community to double (doubling time) 
 
An increase in the percentage of COVID-19 tests suggestive of active infection 
that are positive for COVID-19 
 
An increase in indicators of health system stress, such as reductions in personal 
protective equipment, hospital bed, or ventilator capacity, and increases in 
emergency medical system calls 
Significant changes in one or more of the warning indicators, or increased numbers of hot spots may 
indicate a relevant increase in community transmission rates of COVID-19 or increased stress on 
the healthcare system. Any of these should lead to consideration of re-implementation of specific 
interventions or resumption of Phase I by leaders and health authorities. 
Phase III: Easing of restrictions in the context of improving conditions 
Phase III represents a further easing of restrictions that would be possible in the setting of effective 
treatment or other medical or public health advances8. During this phase, the current COVID-19 
epidemic has been controlled, with decreasing incidence of new infections, appropriate support for 
medically at-risk populations, and effective public, community, and business partnerships for 
effective monitoring, testing, tracing, and isolation. Conditions should also be in place that ensure 
the risk of COVID-19 infection is significantly reduced either through effective and safe 
therapeutics that prevent infection, spread, and/or progression to severe illness or widespread 
immunity to COVID-19 
Suggested approaches and strategies to guide Phase III activities include: 
• Continue increased capacity in operations across businesses and enterprises 
• Continue universal hand hygiene and surface cleaning standards 
• De-escalate restrictions related to isolation, social distancing, modified work environments 
and schedules 
• High risk businesses and enterprises--those not meeting safety guidelines--will receive 
targeted support, education, and restrictions until standard guideline conditions are met 
• For de-escalation of restrictions related to school, sports, travel, and large/mass gatherings: 
coordinate with state and federal agencies 
Throughout Phase III, public health authorities will monitor warning indicators as signs that 
increased public health safety measures or a return to Phase I or II mitigation and assessment 
strategies may be needed. It is likely that additional warning indicators will be appropriate at this 
time, but these could include the same warning indicators as noted in Phase II. 
Phase IV: Pandemic Preparedness 
The objective of phase IV is increasing readiness for the next public health threat; this could begin 
during Phase III activities.8 Readiness implies investment in the scientific, public health and medical 
infrastructure with attention to community resilience and trauma informed care for community 
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psychological and social well-being. This phase should provide opportunity to remedy the health 
system, public health and preparedness deficiencies that were revealed by the pandemic, leading to a 
more equitable distribution of resources for healthcare access, education, and prevention activities. 
We should be able to identify and test all suspected cases, promptly isolate and care for confirmed 
cases, identify and quarantine close contacts of confirmed cases.  
Recommended activities during this phase include: 
• Local capacity building 
o Invest and modernize the Metro Health’s public health system to ensure critical 
public health protections are in place for every person in Bexar County, that the 
public health system is prepared and has the right resources to address emerging 
health threats, and that the public health system is engaged daily to eliminate health 
disparities. Funding is needed to improve communicable disease data systems that 
are used across the county and to improve how population health data are collected, 
reported, and made available to municipalities and partners who rely on them. 
o Strengthen the Southwest Texas Regional Advisory Council (STRAC): one of 
twenty-two regional advisory councils in Texas that comprise the Texas Trauma / 
Emergency Healthcare system 
o Modernize and fortify the Healthcare System: improve hospital bed and ICU 
capacity to accommodate large surges of patients through a Hospital Preparedness 
Program, expand supply chain of personal protective equipment, and precautionary 
measures.  
• Biomedical research 
o Develop vaccines for novel viruses rapidly, support flexible manufacturing capacity 
to scale up production to a global level in an emergency. 
o Participate in ongoing research to be prepared to move quickly towards widespread 
asymptomatic testing, vaccines and a cure. 
• Augment disaster preparedness 
o Agree upon indicators and case rates, for any disease, that constitute a public health 
threat.  
o Develop a city/county crisis plan including phases from containment to 
reestablishment of commerce post threat, and consideration of marginalized 
communities. 
o Have a public relations and media plan in place to inform and engage the public 
o Fully document successes, lessons learned, and challenges with the current public 
health threat and any future health threats with special attention to:  
 improved alertness, responsiveness, and adaptability for both public health 
and business operations to pandemic threats, 
 protecting populations most at risk for adverse outcomes and long-term 
consequences, and 
 embed racial and economic equity principles into the updates of all local 
emergency preparedness plans. 
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o Advocate for a National Infectious Disease Forecasting Center whose primary focus 
would be to ensure a timely response to any public health threat that affects the 
country, state, or county.  The national response team would also be prepared to 
develop a federal emergency plan to assist state and local governments with 
guidelines, infrastructure, and resources to contain the threat and slow or stop a 
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Risk assessment by sector 
Reopening businesses and other sectors of the economy in San Antonio and Bexar County will 
require close consideration of the risk of someone becoming infected with SARS-CoV-2, the virus 
that causes COVID-19, across many settings. While mitigation strategies can be put in place to 
reduce the likelihood of community transmission, control of community transmission cannot be 
guaranteed. Thus, careful monitoring of community spread will be required, and strict social 
distancing measures may need to be re-instituted if a resurgence is detected. Vigilant management of 
COVID-19 cases will be required throughout the pandemic, even after the peak transmission period 
when businesses and other sectors of the economy start re-opening.  
Commonly, the risk of transmitting COVID-19 has been compared to that of the spread of the 
Influenza.  However, COVID-19 and Influenza are distinctly different infections with different 
characteristics of transmission.  For instance, SARS-CoV-2 may be carried in the nasopharynx of a 
high percentage of infected persons who are asymptomatic.  It has recently been reported in an 
Icelandic population that 43% of people with a positive test were asymptomatic in overall 
population screening10 and 56% of nursing home residents screened in a Seattle skilled nursing 
facility during a COVID-19 outbreak were asymptomatic.11  Finally, COVID-19 has the potential to 
spread rapidly and overwhelm medical resources, resulting in the possibility of the loss of life among 
individuals who might have otherwise survived with adequate medical supportive care.  
Though there are many things we do not yet know about SARS-CoV-2 and COVID-19, there is 
clear evidence on what types of activities put people at risk. Our consensus recommendation for 
staging the opening of activities and businesses is to focus on the potential for viral transmission and 
mitigation instead of trying to define whether particular activities or businesses are essential or not. A 
guidance document prepared by the Johns Hopkins Bloomberg School of Public Health’s Center for 
Health Security recommends ranking activities by the risk of transmission.12 This risk is determined 
by three characteristics: 
1. Contact intensity: Are people in this setting close to one another (<6 feet) or farther away? 
How long are people in this setting in contact with one another? For example, low contact 
intensity would be walking past someone in a store; high contact intensity would be sharing 
an apartment with someone. 
2. Number of contacts: How many people will be in the setting at the same time? Higher 
numbers of people in the same place at the same time raise the risk for COVID-19. 
3. Modification potential: This considers how easy it is to modify the activity or setting to 
reduce risk. Settings where it is easier for people to remain 6 feet apart have higher 
modification potential. The U.S. Centers for Disease Control and Prevention has a 
document that describes these “mitigation strategies” across many different settings.13 For 
more information see Appendix III which  includes a list of mitigation resources. 
The tables below describe the risk of infection (contact intensity and number of contacts) for many 
different sectors of our community and the possibility of modifying or reducing the risk. We added 
an overall risk assessment for each sector. Please know, these assessments are not based on a 
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mathematical assessment of risk but may help to provide an overall idea of how risky a specific 
activity could be. All risk assessments could vary based on mitigation strategies or advances in our 
ability to prevent infection in specific contexts. The assessment of risk will require an analysis of the 
characteristics mentioned above. Furthermore, the risk assessment of individual businesses and 
other sectors of the economy will have to be fluid, frequently updated, and modified as necessary 
based on evolving data and scientific breakthroughs. 
All tables in this section are adapted from the guidance prepared by the Johns Hopkins Bloomberg 
School of Public Health’s Center for Health Security.12 









Restaurants1 Medium Medium Medium Medium 
Bars1 High High Medium High 
Salon, spas, and other personal 
care industries 
Medium/high Low Medium Medium 
Retailers Low Medium Medium Low 
Shopping malls Low Medium Medium Low 
Gyms/fitness studios Medium Medium Medium Medium 
Theaters, museums, and other 
indoor leisure spaces 
Medium High Medium Medium 
Outdoor large venues (concerts, 
sports) 
High High Medium High 
Indoor large venues (concerts, 
sports) 
High High Poor High 
1Specific mitigation strategies may be developed for outdoor restaurants and bars, which would be more aligned 
with the outdoor spaces table. 
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Table 4. School and Childcare Facilities 
Please note that our current knowledge of transmission dynamics in children is low. More 
information about the impact of mitigation strategies, such as symptom and temperature screening 










Childcare facilities (daycare, 
preschools) High Medium/High Poor/Medium High 
Schools (elementary, middle, and 
high) 
High High Poor High 
Contact school sports High Medium/High Poor High 
Noncontact school sports Low Medium Good Low 
School performing arts High Medium/High Medium Medium 
Summer camps High High Poor High 
Institutions of higher education High High Good Medium 
Residence halls and other 
overnight programs 
High Medium Poor High 
 










Parks, walking paths/ trails, dog 
parks 
Low Low Poor Low 
Athletic fields and other outdoor 
congregate settings 
Medium Medium Poor Medium 
Pools Medium Low Good Low 
Playgrounds, skateparks, and other 
outdoor recreation spaces 
Medium Medium Medium Medium 
 










Places of worship High High Medium High 
Libraries Low Low Medium Low 
Community centers Medium High Medium Medium 
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Total Risk Score 
Buses High High Medium High 
Metros/rail High High Medium High 
Airplanes High High Medium High 
Rideshare/taxis High Low Poor Medium 
 








Total Risk Score 
Sports related mass gatherings: 
games, tournaments, 
championships 
High High Medium High 




Medium Medium Medium 
Religious related mass gatherings: 
large celebrations, festivals, 
pilgrimages 
High High Medium High 
Business-related mass gatherings: 
trade shows, conferences, 
conventions, workshops, retreats 
High High Good Medium 
Entertainment-related mass 
gatherings: large concerts, 
festivals, carnivals, 
conventions, shows 
High High Medium High 
Politically related mass gatherings: 
election rallies, polling centers, 
parades, speeches/ addresses 
High High Medium High 
 









Small social gatherings (<50) High Medium Good Medium 
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Principles for a Common-Sense, Street-Smart Recovery with a Focus on 
the Most Marginalized 
 
Guiding Statement 
Racial and economic disparities are vast and deep in San Antonio, and specific details about these 
local disparities can be found in the supporting documents included in the Appendix IV:  
1. San Antonio Racial Equity Indicator Report 
2. San Antonio Poverty Report 
San Antonio should prioritize the needs of those most impacted by the COVID-19 pandemic by 
focusing response and recovery efforts in low-income communities, communities of color 
(Latinx/Hispanic, Black/African American, Indigenous and Native, Asian/Pacific Islander, etc.), 
and LGBTQIA+ communities. This is an intersectional strategy that ensures that all who are highest 
risk are reached, including people with disabilities, the medically vulnerable, low wage frontline 
workers, imprisoned individuals, housing insecure individuals, seniors, and many others., as when 
these individuals are also low-income and/or from communities of color they are the most at risk. 
We recognize that we have not distinctly named all of groups of people who are disenfranchised, but 
they are all included, as we use the term marginalized populations to explicitly refer to the 
communities most at risk due to systems and structures of oppression. 
San Antonio can best meet the economic needs of businesses and the public, by recognizing the 
contributions of, and paying fairly for, the labor of essential workers and their families. As we begin 
to think about recovery, we must commit to become a better and more equitable city and a better 
and more just nation than we were before this pandemic.  
Recommended Actions 
Action: Center Racial and Economic Equity 
Centering racial and economic equity must be at the core of this recovery and be a required core 
principle of the response and recovery efforts in all City Departments, county efforts, COVID-19 
task forces, and committees. 
Why? Low-income people and people of color will experience the worst impacts of this crisis. 
Therefore, now is the time to step up efforts to sustain equity gains that have already been made and 
secure more. 
Action: Put Marginalized People First and Make Sure They are in the Room 
The scale and duration of relief must match the scale and duration of the need and low-income 
people and people of color must shape the recovery decisions that affect their lives and communities. 
Ensure representation of marginalized community members on all COVID-19 response related task 
forces and committees. 
Why? Since 2013, the overall poverty rate for the City of San Antonio has remained at 18-20%, 
indicating that about one in five individuals are experiencing the financial and social burdens of 
poverty. Poverty is one of the most important determinants of health, longevity, and quality of life. 
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Roughly 60 percent of Americans do not have enough savings to cover a $1,200 emergency expense. 
The vast racial wealth gap leaves households of color especially vulnerable right now.14 Two out of 
three households of color do not possess enough savings to sustain themselves for three months if 
their income were disrupted; and one-third of African Americans and Latinos have no financial 
assets at all. Building the long-term financial security of low-income households and households of 
color involves harnessing an array of resources and institutional supports that enable vulnerable 
families to thrive and move up the economic ladder.15 
We must address the dire human need and support people to manage their lives by protecting and 
expanding the safety net for everyone, regardless of status, and delivering emergency aid in the form 
of direct cash payments, debt forgiveness, rent and mortgage relief, loans and grants for small 
business owners, and other measures, with specific outreach to marginalized communities. 
In Bexar County, 15% of Latinx/Hispanic community members do not have health insurance. In 
the Black/African American community, more than 30% do not have health insurance.16 In the past 
12 months, 24% of Latinx/Hispanic adults and almost 18% of Blacks/African Americans (non-
Hispanics) did not see a doctor due to cost. In the LGBTQIA+ community, the lack of culturally 
competent care layered on racial and economic inequities has led to even greater health inequities. In 
the past year, 46% of LGBTQIA+ people surveyed said they have avoided seeing a healthcare 
provider in the past year and 30.8% said they had been refused health care.15 The challenges our 
marginalized residents face in accessing health care discourage them from visiting a doctor when 
sick. As a result, individuals in this situation will not seek health care until severely ill, which is worse 
for their health and worse for the healthcare system. 
We need to improve access to care for our most marginalized San Antonio and Bexar County 
residents by including health care enrollment efforts in our community outreach actions and by 
providing resources for medical care options for those who remain uninsured. Recognizing that a 
lack of culturally competent providers is also a barrier to access for many, we must also create and 
promote a list of providers who have demonstrated a commitment to full inclusion of treatment for 
all patients and specifically list which providers are LGBTQIA+ affirming.  
Action: Invest in Community Infrastructure 
The essential social service organizations must be prioritized for safe re-opening in the first phase, 
which should include free training and free distribution of essential supplies that can help prevent 
the spread of COVID-19 in their facilities, such as PPE and cleaning supplies.  
Why? The trusted network of nonprofit, cultural, philanthropic, and local institutions that support 
the well-being and resilience of the most marginalized communities will be called to do more with 
fewer resources. Their work is urgently needed now and essential for the long road to recovery. We 
must commit to continuing to channel funds to help them keep services running and adapt to social 
distancing and online platforms as needed. 
We must target investments to people and institutions rooted in and deeply committed to 
communities, with a track record for getting results for the populations they serve. This must 
include organizations serving low-income communities, the Latinx/Hispanic, Black and African 
American communities, and the LGBTQIA+ communities specifically. 
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Action: Support Free Targeted Testing 
Testing, tracing and supported isolation needs to be made free and available for marginalized 
communities, without the need for a referral, and provided in their neighborhoods and/or via 
mobile testing units. Testing should include a random sample of asymptomatic and all mildly 
symptomatic individuals in these populations. Contact tracing efforts must be expanded (please see 
Indicators and Capacity Section) and their efforts should ensure prompt and prioritized case tracing 
of people with COVID-19 in marginalized communities.17 
Why? The Black/African American community in Bexar County have not escaped the nationwide 
pattern. Black San Antonians account for 25% of COVID-19 deaths and 10% of cases, despite 
making up only 7.2% of the population. Latinx/Hispanics account for 58% of the cases and 46% of 
the deaths.18 Both of these populations experience higher rates of lung disease, heart disease, 
diabetes, obesity, and other risk factors for severe COVID-19 disease.19 
Figure 4. Percentage of known cases and deaths in Bexar County by Race/ Ethnicity, April 20201 
 
1See Table 14 in Appendix IV associated with this graph. All percentages are n/total confirmed cases of COVID-19 to 
date. 
Action: Develop a Community Health Equity Task Force 
With the support of the Mayor and Council and County Commissioners Court, it is recommended 
to launch a “Community Health Equity Task Force” that would be a coordinated effort between the 
Council’s Community Health and Equity Committee, the Mayor’s LGBTQIA+ Committee, Metro 
Health, and the Office of Equity. 
Why? This task force should be primarily composed of community members from the most 
marginalized populations (which includes people of color including immigrants and asylum seekers, 
low-income communities, people with disabilities, and LGBTQIA+) be assembled quickly, and 
remain in place for at least 18 months, recognizing that the response efforts needed to address 









AI/Alaskan Native Asian Black White Hispanic
Bexar Population Cases Deaths
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The Task Force would act in an advisory capacity to the Mayor of the City of San Antonio and 
Bexar County, as well as the City of San Antonio Departments, and at a minimum would do the 
following: 
1. Study the causes of racial disparities for COVID-19 and recommend actions to address such 
disparities. 
2. Recommend actions to increase collection of and access to data regarding the racial and 
ethnic impact of COVID-19, and impacts on marginalized communities including: 
a. remove barriers to accessing physical and mental health care 
b. reduce the impact of medical bias in testing and treatment 
c. mitigate environmental and infrastructure factors contributing to increased exposure 
during pandemics resulting in mortality 
d. develop and improve systems for supporting long-term economic recovery and 
physical and mental health care following a pandemic. 
3. Perform outreach to ensure all stakeholders in impacted areas are informed, educated, and 
empowered. Stakeholder outreach will include, but is not limited to, community leaders, 
partner organizations, tribal leaders. 
4. Perform outreach to ensure the general public is informed about racial disparities in the 
impact of COVID-19, and the work of the Task Force. 
5. Identify avenues of funding for combating racial disparities in the impact of COVID-19. 
6. Recommend changes in San Antonio City and Bexar County policy relevant to combating 
racial disparities in the impact of and response to pandemics. 
7. Identify other issues and provide recommendations to the City of San Antonio and the 
County on any other matters relevant to addressing racial disparities in the impact of and 
response to pandemics. Specific concerns could include: fear of testing positive and 
consequent job loss, contact tracing and possible deportation of undocumented immigrants. 
 
Action: Build an Equitable Economy 
Prioritize the needs of small and minority owned businesses and their employees. 
Why? Providing direct support to workers and helping small and micro-businesses (<50 employees) 
preserve jobs through the mandated shelter-in-place orders is the best economic policy right now, 
and will yield the best results for a sustained economic recovery that will benefit everyone. Ensure 
that the needs of the small and minority owned businesses are addressed during every phase of the 
re-opening. This could include targeted relief, loans, and guidance on how to implement best 
practices relating to virus prevention techniques within their businesses. The health of San Antonio 
and Bexar County residents will also be improved by providing increased support for workforce 
development programs. April 3rd, 2020, Ramiro A. Cavazos, president and CEO of the U.S. 
Hispanic Chamber of Commerce, estimated that 1 in 4 Latinx/Hispanic owned enterprises may 
never reopen20, and we know that the health and well-being of our marginalized communities is 
heavily intertwined with their economic well-being. It is probable that these estimates are 
considerably higher now, three weeks later, and also higher in San Antonio specifically, based on the 
high number of Latinx/Hispanic owned enterprises in our city that routinely operate with tight 
COVID-19 Health Transition Team Report – April 27, 2020 Page 35 
margins. In 2010 there were 37,000 Hispanic-owned businesses in San Antonio, according to the 
Texas Governor's Office.21  
 Breakthroughs 
Any plan must be adaptable to new developments. Over the next six months or more, new research and breakthroughs in testing and 
treatment will require changes to the current plans. Following is a chart describing each of these factors and how we would recommend 
addressing them. 
Table 10. Breakthroughs in testing 
Breakthrough What would change? Current barriers Current possible workaround Resources needed 
Rapid on-site testing  
at work sites and mass 
gatherings 
More uninfected people 
able to gather 
 
Early identification of 
asymptomatic people 
• Current test requires 
moderate to high 
complexity lab 
• Limited supplies: 
reagents, swabs, 
viral medium 
● Work sites could require serial 
testing 
● All employees regardless of 
symptoms 
● Employees in direct public 
contact 
● Establish quarantine facilities for 
workers to live away from 
households (not practical for mass 
gatherings) 
● Many mobile testing units 
● Quarantine facilities 
● More hotels 
● Wraparound services at 
those hotels, incl. childcare 
● Different from current 
isolation facilities, which do 
not allow residents to leave 
at all 
Serology Testing 
Antibody testing with high 
validity and reliability 
 
Consensus that immunity 
is protective and long 
lasting 
 
Not for diagnosis of 
current infection. Antibody 
tests can be used for 
population studies and to 
measure herd immunity 
Previously infected 
people able to work and 
serve as caretakers 
● They would still use 
protection, but it 
could help stabilize 
the workforce by 
reducing exposure to 
workers who haven’t 
been infected 
 
Potential plasma donors 
available for treatment 
• Need results of 
antibody test studies 
• Need results of 
immunity studies 
• Concern that using 
immunity as qualifier 
will make people 
want to become sick 
(like chicken pox 
parties) 
• False positives 
would give a false 
sense of security 
• People with severe illness who 
require hospitalization may be 
immune for an undetermined period 
of time 
● Should not require immune “proof” 
for work. It can be voluntary. If a 
person has COVID-19 recovery, 
immune status may be inferred, and 
they can work in higher risk 
environments. May be useful for 
healthcare workers treating COVID-
19 patients 
● FDA approved antibody tests 
 
● Database management of test 
results 
 
● Collaboration with academia 




e.g. saliva tests 22 vs nose-
throat swab vs nostril 
● Reduced need for PPE 
in Collection 
● More likely to get a 
better sample – less 
• Saliva not currently 
accepted by CDC for 
diagnosis 
• Unclear how often 
Current nose-throat (nasopharyngeal) 
swab at clinic or drive-through 
Assess all tests as they become 
available 
● Testing Task Force 
● Outside Researchers 
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swab; home test kits painful to the patient 
and more willing to 
repeat test 





Table 11. Breakthroughs in treatment 
Breakthrough What would change? Current barriers Current possible workaround Resources needed 
Safe and Effective 
treatment that is widely 
available, regardless of 
income 
Reduced public fear 




• Studies on-going 
• Lack of access to 
many of these 
medicines 
• Lack of access to 
health care related 
to barriers of cost 
and cultural factors 
impacting key 
populations  
● Non-pharmaceutical interventions 
such as physical distancing 
● Education and Outreach 
● Lay groundwork to ensure that 
treatments will be available at low 
cost to call 
● Education and outreach, 
including messaging that is 
culturally responsive 
● Utilize Community Health 
Workers 
● Identify funding resources for 
treatments and office visits for 
those without insurance 
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Table 12. Breakthrough with vaccine 
Breakthrough What would change? Current barriers Current possible workaround Resources needed 
Safe and effective vaccine 
 
Available to all with no 
out of pocket expense, 
regardless of insurance 
status 





~18 months off 
2) Vaccine hesitancy 




● May not 
achieve herd 
immunity.24  
● Lack of access 
to health care 
● Non-pharmaceutical interventions 
such as physical distancing 
● Education and Outreach regarding the 
importance of vaccination 
● Legislative advocacy for vaccination 
requirements (note this is only likely to 
impact school aged population) 
● Lay groundwork to ensure that vaccine 
will be available at low cost to all 
● Education and outreach, 
materials and expertise to 
craft messaging that: 
● Is culturally responsive 
● Addresses vaccine hesitancy 
● Includes legislator education 
● Identify funding resources for 
vaccines without insurance 
● Establish school-based clinics 
and mobile vaccine clinics 
● Target high risk populations 
within the community 
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Table 13. Breakthrough in knowledge of disease transmission 
Breakthrough What would change? Current barriers Current possible workaround Resources needed 
Role of Children 
● Children are less likely 
to be very sick, but 
they do become 
infected. It’s not clear 
what role they play in 
transmission25-28 
Role of Asymptomatic and 
Pre-symptomatic 
Infection 
● Infected but 
asymptomatic or pre-
symptomatic people 
can potentially spread 
SARS-CoV-2 
● Not yet clear how 






● Impact school 
closures  
● Better define need 
(or not) for face 
masks 
1. Ongoing research 
2. Data are unclear 






the level or impact 
on community 
spread is unclear 
● Non-pharmaceutical interventions 
such as physical distancing 
● Testing of employees with high 
likelihood of multiple public contacts 
during the course of their assigned 
duties to identify asymptomatic 
carriers 
 
● Monitor and evaluate further 
studies as they become 
available 
● Address needs to school 
districts should physical 
distancing be required for 
return to school  
 




Appendix I: Glossary of terms 
Active infection: An infection is present, sometimes active infections are only associated with 
symptoms, or feeling ill with the disease. Some active infections can be present, and even 
contagious without making a person feel ill or “symptomatic” 
Asymptomatic: A person who has no physical features, or symptoms, of a specific illness. For 
example, in COVID-19 someone who does not have cough, fever, shortness of breath, or any 
other symptoms. 
Communities of color: For the purposes of this document, communities of color are composed of 
people who are Latinx/Hispanic, Black/African American, Indigenous and Native, Asian or 
Pacific Islander. These also include immigrants or asylum seekers who fall into this category. 
Contact intensity: This is a part of assessing the risk of a specific activity and is determined by the 
contact type (ranging from close to distant) and duration (ranging from brief to prolonged) of 
the contact. 
COVID-19: Is an abbreviation for “coronavirus 2019” and is the name for the illness caused by a 
new coronavirus, called SARS-CoV-2 that usually causes a severe flu with cough, fever, body 
aches, and can progress to pneumonia and even death. This new illness was first discovered in 
December 2019 and has now caused a global pandemic. 
Epidemic: A widespread occurrence of an illness, usually an infectious disease, at a particular time 
in a community. 
First responders: Someone designated or trained to respond to an emergency. For example, fire 
fighters, police, emergency medical technicians 
Health care providers: Individual trained to provide care for others. For the purposes of this 
document, this includes nurses, respiratory technicians, doctors, physical therapists, or anyone 
else providing care to patients. 
Health care: Refers to the actions that providers take in caring for patients 
Healthcare: Is the industry or the system that provides medical care to an individual or a 
community 
High Complexity Tests: These are tests that are most difficult to perform or are most subject to 
error. They are usually performed only by large clinical laboratories and require quality control, 
quality assurance, proficiency testing and stricter personnel requirements. The major differences 
in requirements between moderate and high complexity testing is in quality control and 
personnel standards. 
Indicator: A thing, like a trend or a fact, that tells how something is working or the state of 
something. 
LGBTQIA+ communities: This term includes people who are lesbian, gay, bisexual, trans or 
transgender, queer, intersex and asexual, and the plus allows for inclusion of others who are 
non-heterosexual or non-cis-gender but do not fit in those categories. 
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Low-income communities: These are communities where the median household income is at or 
below 80% the median income for their area. For example, in San Antonio and Bexar County, 
this would be a combined income of less than $57,600 for a family of four.  
Marginalized populations: For the purposes of this document, marginalized communities include: 
communities of color including immigrants and asylum seekers of color, low-income 
communities including housing insecure and homeless individuals, people with disabilities, and 
LGBTQIA+ communities 
Medium/Moderate Complexity Tests: Much of the testing performed in clinical laboratories falls 
into this category. Examples of moderate complexity tests are microscopic analysis of urinary 
sediment, some direct antigen strep A tests and some hematology and chemistry tests.  
Mitigation: This is a step or series of steps that people or organizations can take to reduce the risk 
of a certain activity or setting. For COVID-19, reducing the number of people going in to a 
store, making sure they all stay 6 feet apart, and asking people to wear masks are all examples of 
mitigation. 
Modification potential: This is a part of assessing the risk of a specific setting or activity and is 
determined by the degree to which changes in the activity (eg, the space, the number of people) 
can reduce the risk. 
Nasopharyngeal swab: A method for collecting a clinical test sample of nasal secretions from the 
back of the nose and throat. The swab is difficult to do correctly and can be 
uncomfortable/painful for the patient. False negatives due to sampling technique as well as 
timing of specimen collection may be common with these swabs.  
Number of contacts: This is a part of assessing the risk of a specific activity and is determined by 
the approximate number of people in a setting or doing an activity at the same time, on average. 
Pandemic: A disease that is present across many countries around the globe. 
Medically at-risk: for the purposes of this document and COVID-19, we know that persons 65 
years and older or with chronic health conditions such as hypertension, diabetes, obesity, or 
immunocompromise 
Pre-symptomatic: Someone who has a disease but has not yet developed symptoms (become sick) 
from it. These people will eventually become ill. 
Progress indicators: These are things that tell us that we are moving in the right direction in 
controlling the COVID-19 epidemic. 
Public facing role: these are any workers or volunteers that interact with members of the public. 
For example, a checkout person at a supermarket or a front desk worker at a clinic have public 
facing roles. A person working in a factory that is not open to the public does not have a public-
facing role. 
SARS-CoV-2: This stands for severe acute respiratory syndrome coronavirus 2, the name of the 
new virus that causes COVID-19. 
Sensitivity: The proportion of true-positives which actually test positive; how well a test is able to 
detect positive individuals in a population.  
Specificity: The proportion of true-negatives which actually test negative; how well an assay 
performs in a group of disease negative individuals.  
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Symptomatic: A person who has a sign of an illness, such as a cough or a fever. 
Test for active infection: For the purposes of this document, these are tests that allow you to tell if 
someone is currently infected with SARS-CoV-2, the virus that causes COVID-19. Usually these 
are molecular tests that check for pieces of the virus in a person’s throat or the back of their 
nose. 
Warning indicators: These are things that tell us that the risk of COVID-19 in our community is 
increasing and that we need to make changes to protect ourselves and others. 
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Appendix II: Resources on Air Exchange  
 
American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRE) Position 





COVID-19 specific statements from ASHRAE (direct quotes from position document April 2020, 
refer to ASHRAE for updates): 
Separate from the approval of this position document, ASHRAE’s Executive Committee and 
Epidemic Task Force approved the following statements specific to the ongoing response to the 
COVID-19 pandemic. The two statements are appended here due to the unique relationship 
between the statements and the protective design strategies discussed in this position document: 
Statement on airborne transmission of SARS-CoV-2: Transmission of SARS-CoV-2 through the air 
is sufficiently likely that airborne exposure to the virus should be controlled. Changes to building 
operations, including the operation of heating, ventilating, and air-conditioning systems, can reduce 
airborne exposures. 
Statement on operation of heating, ventilating, and air-conditioning systems to reduce SARS-
CoV-2 transmission: Ventilation and filtration provided by heating, ventilating, and air-conditioning 
systems can reduce the airborne concentration of SARS-CoV-2 and thus the risk of transmission 
through the air. Unconditioned spaces can cause thermal stress to people that may be directly life 
threatening and that may also lower resistance to infection. In general, disabling of heating, 
ventilating, and air-conditioning systems is not a recommended measure to reduce the transmission 
of the virus. 
Who or what is ASHRAE: 
ASHRAE, founded in 1894, is a global society advancing human well-being through sustainable 
technology for the built environment. The Society and its members focus on building systems, 
energy efficiency, indoor air quality, refrigeration and sustainability within the industry. Through 
research, standards writing, publishing and continuing education, ASHRAE shapes tomorrow’s built 
environment today. ASHRAE was formed as the American Society of Heating, Refrigerating and 
Air-Conditioning Engineers by the merger in 1959 of American Society of Heating and Air-
Conditioning Engineers (ASHAE) founded in 1894 and The American Society of Refrigerating 
Engineers (ASRE) founded in 1904. 
Coronavirus (COVID-19) Response Resources from ASHRAE and Others 
ASHRAE has published two statements to define guidance on managing the spread of COVID-19 
with respect to the operation and maintenance of HVAC systems in buildings. ASHRAE 
recommends operators continue to run systems during this time to help control the spread of the 
virus. Read the official statements and affiliated guidance on ASHRAE's official COVID-19 page.  
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Appendix III: Resources for risk assessment by sector 
 
National Restaurant Association  
https://restaurant.org/Covid19 
 
















CDC Small Business guidance 
https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-small-business.html 
 








CDC Guidance for Child Care Programs that Remain Open 
https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/guidance-for-
childcare.html 








CDC Guidance for Administrators in Parks and Recreational Facilities 
https://www.cdc.gov/coronavirus/2019-ncov/community/parks-rec/park-administrators.html 
 
National Collegiate Athletic Association Coronavirus (COVID-19) 
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http://www.ncaa.org/sport-science-institute/coronavirus-covid-19 
 
American Camp Association, Association of Camp Nursing 
https://www.acacamps.org/resource-library/coronavirus-information-camps 
 
American College Health Association 
https://www.acha.org/COVID-19 
 
CDC Interim Guidance for Administrators of US Institutions of Higher Education 
https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-ihe-response.html 
 




Guidance from Maryland: Parks 
https://dnr.maryland.gov/publiclands/Pages/COVID-19-Personal-Spacing-at-Parks.aspx 
 
Guidance from Rhode Island: Parks 
http://riparks.com/covid19.php 
 
Guidance from Los Angeles CA, Parks 
https://www.laparks.org/covid-19 
Guidance from the National Mall Trust in Washington, DC 
https://nationalmall.org/coronavvirus 
 
CDC Water and COVID-19 FAQs: Pools 
https://www.cdc.gov/coronavirus/2019-ncov/php/water.html 
 




Guidance from Orange Beach, AL, Beaches, Piers 
https://www.orangebeachal.gov/news/covid-19-updates 
 
Guidance from RI, Beaches, Piers 
http://riparks.com/covid19.php 
 
Guidance from MD, Parks 
https://dnr.maryland.gov/publiclands/Pages/COVID-19-Personal-Spacing-at-Parks.aspx 
 
Guidance from Santa Cruz, CA, Parks 
http://www.cityofsantacruz.com/government/city-departments/parks-recreation/covid-19 
 
CDC Resources for Community- and Faith-Based Leaders 
https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/index.html 
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FAQ for Faith Leaders from NYC 
https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-faith-faq.pdf 
 













CDC Resources for Community- and Faith-Based Leaders 
https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/index.html 
 
Guidance from Baltimore County Public Library  
https://www.bcpl.info/blog/2020/the-library-and-covid-19 
 












CDC What Bus Transit Operators Need to Know About COVID-19 
https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/bus-transit-operator.html 
 









CDC What Rail Transit Operators Need to Know About COVID-19 
https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/rail-transit-operator.html 
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WHO Practical considerations and recommendations for religious leaders and faith-based 
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Appendix IV: Additional Data from ‘Principles for a Common-Sense, Street-Smart 
Recovery with a Focus on the Most Marginalized’ 
 
San Antonio Racial Equity Indicator Report 
https://www.sanantonio.gov/Portals/0/Files/Equity/IndicatorReport.pdf 
San Antonio Poverty Report 
https://www.sanantonio.gov/Portals/0/Files/HumanServices/FaithBased/2019PovertyReport.pdf 
The Health Collaborative. (2016). 2016 Bexar County Community Health Needs Assessment Report. 
San Antonio, TX: The Health Collaborative.  
http://healthcollaborative.net/wp-
content/uploads/2019/10/Community2019_CHNAReport_compressed.pdf 




Metropolitan Health District: COVID-19 SURVEILLANCE DASHBOARDS 
https://www.sanantonio.gov/Health/News/Alerts/CoronaVirus 
 
Table 14. Known cases and deaths in Bexar County by Race/Ethnicity, April 2020 




AI/Alaskan N 2.50% 2 (0.17%) - 
Asian 2.50% 40 (3.42%) 1 (2.33%) 
Black 7.20% 120 (10.27%) 11 (25.58%) 
White 27.50% 319 (27.29%) 11 (25.58%) 
Hispanic 60.30% 690 (59.02%) 20 (46.51%) 
Total  1169 43 
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Appendix V: Scientific information on breakthroughs 
 
COVID-19 Testing 
There are two types of tests cleared for emergency use by the FDA: 
• Molecular tests are diagnostic for acute infection. These identify the presence of specific 
nucleic acids produced by the virus within swabs and respiratory samples. These are 
currently in use. 
• Serology tests look for antibodies against SARS-CoV-2, the virus that causes COVID-19. 
These identify if the person has immunity. 
Molecular tests 
SARS-Cov2 only contains RNA, which means it relies on infiltrating healthy cells to multiply and 
survive.  A sample is collected from the nose or throat and is treated with several chemical solutions 
to remove proteins and fats. In order to detect the virus, technicians need to convert the RNA to 
DNA so they can copy the sample (reverse transcription) hundreds of thousands of times 
(amplification). This produces a large enough quantity of the viral DNA to confirm the presence of 
SARS-Cov2. The sample mixture is then placed in an RT-PCR machine that cycles through 
temperatures that heat and cool the mixture to trigger specific chemical reactions. A standard real 
time RT-PCR setup usually goes through 35 cycles, which means it creates around 35 billion copies 
of the viral DNA in the sample. 
With good sampling technique, RT-PCR, in general, is sensitive and specific and can deliver a 
reliable diagnosis. It continues to be the most accurate method available for detection of the 
coronavirus. The difference between the automated RT-PCR and a manual RT-PCR is comparable 
to a boxed cake mix and a cake made from scratch.  The automated kits have significant benefits by 
reducing the risk of cross-contamination and minimizing errors caused by manual interventions.  
The manual RT-PCR can lead to more sample-to-sample variation, less reproducibility, and less 
precision when mixing reagents (like a cake from scratch where you measure all the ingredients).   
Many of the approved tests require nasopharyngeal (NP) swabs, which is a sample of secretions 
from the back of the nose and throat. The NP swab is difficult to do correctly and can be 
uncomfortable for the patient thus resulting in false negatives due to poor sampling technique. 
Given the supply issues with swabs and reagents, another type of test would be ideal. 
Serology tests 
The FDA granted approval for four antibody tests as of April 23, 2020. Usually within a few days 
after infection, the body’s immune response produces antibodies called IgM. Later, the immune 
response produces long lasting antibodies called IgG. These IgG antibodies are specific to the virus.  
In some cases, it can take up to 11 days for an individual’s immune system to produce the antibodies. 
That’s why the tests are not used to diagnose patients with COVID-19 that are showing symptoms 
within the first two or three days. Antibody tests could be valuable to determine if a person was 
infected in the past.  IgG antibody positivity suggests the person is recovered and may be protected 
COVID-19 Health Transition Team Report – April 27, 2020 Page 50 
from future infection, which would be valuable to know for healthcare workers. At this point, it is 
unclear how long immunity lasts, and there are concerns about false positive results.  If reliable and 
valid tests become available, healthcare and other critical workers could be prioritized. The 
recovered workers could be assigned COVID-19 patients, still using appropriate personal protective 
equipment. This could help stabilize the workforce by reducing exposure to the workers who 
haven’t been infected. 
Testing Terms  
Medium/Moderate Complexity Tests: Much of the testing performed in clinical laboratories falls 
into this category. Examples of moderate complexity tests are microscopic analysis of urinary 
sediment, some direct antigen strep A tests and some hematology and chemistry tests.  
High Complexity Tests: These are tests that are most difficult to perform or are most subject to 
error. They are usually performed only by large clinical laboratories and require quality control, 
quality assurance, proficiency testing and stricter personnel requirements. The major differences in 
requirements between moderate and high complexity testing is in quality control and personnel 
standards.  
Nasopharyngeal swab: A method for collecting a clinical test sample of nasal secretions from the 
back of the nose and throat. The swab is difficult to do correctly and can be uncomfortable/painful 
for the patient. False negatives due to sampling technique as well as timing of specimen collection 
may be common with these swabs.  
Sensitivity: The proportion of true-positives which actually test positive; how well a test is able to 
detect positive individuals in a population.  
Specificity: The proportion of true-negatives which actually test negative; how well an assay 
performs in a group of disease negative individuals.  
Treatment 
Currently, there are no approved treatments for patients infected with COVID-19.  While many 
people with COVID-19 have mild symptoms and can remain at home, it can take 10-14 days to clear 
the infection. During this time they are contagious to others.  An effective treatment could shorten 
the number of days they’re contagious, limiting the spread of the virus.  Hospital care is limited to 
experimental treatments and supporting and preserving vital functions.32  If a pharmaceutical 
treatment becomes available, not only will this save lives, it will reduce fear among the public.   
Vaccination 
Scientists around the world are researching and testing vaccine candidates against COVID-19.  
While efforts are being made to speed up the process of vaccine development, experts warn it may 
be 12-18 months before a vaccine is available.33 
A safe and effective vaccine can halt the spread of disease dramatically.  We need to prepare over the 
next six to 12 months for the mechanisms necessary to deliver the vaccine. For example, how can 
we set up clinics? Can we use schools? How do we get adults to come in for vaccination?  Older 
adults will remember people lining up to get the polio vaccine when it first became available.34 
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There is currently an NIAID-sponsored Phase I Vaccine Trial underway in Seattle, Atlanta, and 
Bethesda.35  This trial includes 45 healthy adults, ages 18-55, 30 healthy adults ages 56-70 and 30 
healthy adults over 71 years old. 
Below are some vaccine candidates in the United States.36  There are more than a dozen studies 
worldwide. 
Table 15. Examples of vaccine trials for COVID-19 underway in the U.S. 
Developers Status 
Moderna and US Government Phase I clinical trial underway in Seattle; Preparing for Phase 2 and 3 
clinical trials to begin upon successful completion 
Johnson & Johnson and US Government Aiming to initiate a Phase 1 clinical study in September 2020, with 
clinical data on safety and efficacy expected to be available by the end 
of the year. This could allow vaccine availability for emergency use in 
early 2021.37 
Inovio Pharmaceuticals Phase I trial underway with plans to manufacture 1 million doses of its 
candidate this year. 
 
New Research 
Much is still unknown about SARS-CoV-2. We must be prepared to adjust our plans in light of new 
research.  
There is still some confusion on the role children play in the spread of COVID-19. While the data 
have been consistent that children are less likely to become severely ill, they do get infected. Unlike 
many other viruses, it’s unclear if children shed the virus as much as adults do.25-28 As we learn more 
about the role of children, this will influence safety practices in schools.  
An asymptomatic person is one who is infected with the virus but never develops symptoms. A pre-
symptomatic person is one who is infected and not yet showing symptoms when tested but later 
develops symptoms. Scientists believe infected people can transmit the virus early in the course of 
infection when symptoms are not yet noticeable. A pre-symptomatic person is believed to be 
contagious one to three days before symptoms develop.38  Due to this potential for transmission, we 
have recommended face masks when one is likely to be in contact with others. However, it’s still 
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